TCTR20220720010已完成3 期
Daily single-strength versus thrice-weekly double-strength trimethoprim/sulfamethoxazole for Pneumocystis jirovecii prophylaxis in solid organ transplant recipients: A randomized control trial
Faculty of Medicine Ramathibodi Hospital0 个研究点目标入组 200 人开始时间: 2022年7月20日最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15 Years 至 N/A (No limit)（—）
- 性别
- All
入选标准
- •All adult SOT recipients
排除标准
- •Unwilling to participate
- •TMP/SMX allergy
研究者
相似试验
已完成
4 期
Daily single-strength vs. thrice-weekly double-strength trimethoprim/ sulfamethoxazole for Pneumocystis jirovecii prophylaxis in kidney transplant recipients: A non-inferiority randomized control trialrenal transplantliver transplantheart transplantcotrimoxazolebactrimPneumocystisTransplant RecipientsTCTR20240329004/A65
已完成
2 期
Comparison of the effect of single and twice daily administration of ranitidine in relief of morning abdominal pain and nausea in childreabdominal pain and nausea.Unspecified abdominal painIRCT20171211037830N2Deputy of Research of Golestan University of Medical Sciences150
尚未招募
4 期
Prophylactic Therapy in HemophiliaCTRI/2018/08/015235Intramural research grant from UCMS
尚未招募
4 期
Glargine once versus twice dailyCTRI/2023/10/059275surbhi bharti
已完成
1 期
Effectiveness and Safety of Once or Twice Daily Mometasone Nasal Spray Versus Amoxicillin Versus Placebo for Treatment of Acute Rhinosinusitis (Study P02683)PER-008-03SCHERING PLOUGH DEL PERU S.A.,